Literature DB >> 12843009

Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein.

Satoshi Ogata1, Ruth Huab Florese, Motoko Nagano-Fujii, Rachmat Hidajat, Lin Deng, Yonson Ku, Seitetsu Yoon, Takafumi Saito, Sumio Kawata, Hak Hotta.   

Abstract

The NS3 protein of hepatitis C virus subtype 1b (HCV-1b) isolates obtained from 89 patients with hepatocellular carcinoma (HCC) and 78 patients without HCC were analyzed. On the basis of the secondary structure of the amino-terminal 120 residues of NS3, HCV-1b isolates were classified into group A, group B, and an indeterminate group, each of which was further divided into a number of subgroups, such as A1-1, A1-2, A2-1, A2-2, B1-1, B1-2, B2-1, B2-2, C-1, C-2, and C-3. HCV-1b isolates of subgroup B1-1 were found in 53 (59.6%) of 89 patients with HCC and 19 (24.4%) of 78 patients without HCC, with the difference between the two patient groups being statistically significant (P < 0.00001). Although the number of isolates was small, subgroup B2-1 was also highly associated with HCC, with all five isolates in that subgroup being found in patients with HCC (P < 0.05). On the other hand, HCV-1b isolates of subgroup A1-1 were associated only weakly with HCC; they were found in 6 (6.7%) of 89 patients with HCC and in 25 (32.1%) of 78 patients without HCC, with the difference between the two patient groups being statistically significant (P < 0.0001). The other subgroups, such as A1-2, A2-1, B1-2, C-1, C-2, and C-3, were moderately associated with HCC; their distribution patterns among patients with HCC did not differ significantly from those among patients without HCC. Taken together, our results suggest that HCV-1b isolates of subgroups B1-1 and B2-1 are highly associated with HCC and that this secondary structure analysis may be useful for predicting the relative risk of developing HCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843009      PMCID: PMC165328          DOI: 10.1128/JCM.41.7.2835-2841.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.

Authors:  S Bruno; E Silini; A Crosignani; F Borzio; G Leandro; F Bono; M Asti; S Rossi; A Larghi; A Cerino; M Podda; M U Mondelli
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

2.  Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions.

Authors:  R Bartenschlager; L Ahlborn-Laake; J Mous; H Jacobsen
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

3.  Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics.

Authors:  C Lin; B M Prágai; A Grakoui; J Xu; C M Rice
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

5.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites.

Authors:  A Grakoui; D W McCourt; C Wychowski; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  Prevalence of hepatitis C virus sequence variants in South-East Asia.

Authors:  W K Greene; M K Cheong; V Ng; K W Yap
Journal:  J Gen Virol       Date:  1995-01       Impact factor: 3.891

8.  Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.

Authors:  J B Nousbaum; S Pol; B Nalpas; P Landais; P Berthelot; C Bréchot
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

9.  Correlation between secondary structure of an amino-terminal portion of the nonstructural protein 3 (NS3) of hepatitis C virus and development of hepatocellular carcinoma.

Authors:  Satoshi Ogat; Yonson Ku; Seitetsu Yoon; Shigeru Makino; Motoko Nagano-Fujii; Hak Hotta
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

10.  High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.

Authors:  M Giménez-Barcons; S Franco; Y Suárez; X Forns; S Ampurdanès; F Puig-Basagoiti; A Sánchez-Fueyo; J M Barrera; J M Llovet; J Bruix; J M Sánchez-Tapias; J Rodés; J C Saiz
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

View more
  1 in total

1.  Decreased apoptosis in advanced-stage/high-grade hepatocellular carcinoma complicating chronic hepatitis C is mediated through the downregulation of p21 ras.

Authors:  Nahed Baddour; Ebtehal Farrag; Ahmed Zeid; Essam Bedewy; Yousry Taher
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.